Show simple item record

dc.rights.licenseopenen_US
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRUSTAND, Denis
dc.contributor.authorVAN NIEKERK, Janet
dc.contributor.authorRUE, Havard
dc.contributor.authorTOURNIGAND, Christophe
hal.structure.identifierBordeaux population health [BPH]
dc.contributor.authorRONDEAU, Virginie
ORCID: 0000-0001-7109-4831
IDREF: 16662988X
dc.contributor.authorBRIOLLAIS, Laurent
dc.date.accessioned2023-03-20T08:38:45Z
dc.date.available2023-03-20T08:38:45Z
dc.date.issued2023-04
dc.identifier.issn1521-4036 (Electronic) 0323-3847 (Linking)en_US
dc.identifier.urihttps://oskar-bordeaux.fr/handle/20.500.12278/172356
dc.description.abstractEnTwo-part joint models for a longitudinal semicontinuous biomarker and a terminal event have been recently introduced based on frequentist estimation. The biomarker distribution is decomposed into a probability of positive value and the expected value among positive values. Shared random effects can represent the association structure between the biomarker and the terminal event. The computational burden increases compared to standard joint models with a single regression model for the biomarker. In this context, the frequentist estimation implemented in the R package frailtypack can be challenging for complex models (i.e., a large number of parameters and dimension of the random effects). As an alternative, we propose a Bayesian estimation of two-part joint models based on the Integrated Nested Laplace Approximation (INLA) algorithm to alleviate the computational burden and fit more complex models. Our simulation studies confirm that INLA provides accurate approximation of posterior estimates and to reduced computation time and variability of estimates compared to frailtypack in the situations considered. We contrast the Bayesian and frequentist approaches in the analysis of two randomized cancer clinical trials (GERCOR and PRIME studies), where INLA has a reduced variability for the association between the biomarker and the risk of event. Moreover, the Bayesian approach was able to characterize subgroups of patients associated with different responses to treatment in the PRIME study. Our study suggests that the Bayesian approach using the INLA algorithm enables to fit complex joint models that might be of interest in a wide range of clinical applications.
dc.language.isoENen_US
dc.rightsAttribution 3.0 United States*
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/us/*
dc.subject.enBayesian estimation
dc.subject.enComputational efficiency
dc.subject.enINLA
dc.subject.enSolid tumors cancer
dc.subject.enTwo-part joint model
dc.title.enBayesian estimation of two-part joint models for a longitudinal semicontinuous biomarker and a terminal event with INLA: Interests for cancer clinical trial evaluation
dc.title.alternativeBiom Jen_US
dc.typeArticle de revueen_US
dc.identifier.doi10.1002/bimj.202100322en_US
dc.subject.halSciences du Vivant [q-bio]/Santé publique et épidémiologieen_US
dc.identifier.pubmed36846925en_US
bordeaux.journalBiometrical Journalen_US
bordeaux.volume65
bordeaux.hal.laboratoriesBordeaux Population Health Research Center (BPH) - UMR 1219en_US
bordeaux.issue4
bordeaux.institutionUniversité de Bordeauxen_US
bordeaux.institutionINSERMen_US
bordeaux.teamBOSTAT_BPHen_US
bordeaux.peerReviewedouien_US
bordeaux.inpressnonen_US
hal.identifierhal-04036903
hal.version1
hal.date.transferred2023-03-20T08:38:48Z
hal.exporttrue
dc.rights.ccPas de Licence CCen_US
bordeaux.COinSctx_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.jtitle=Biometrical%20Journal&rft.date=2023-04&rft.volume=65&rft.issue=4&rft.eissn=1521-4036%20(Electronic)%200323-3847%20(Linking)&rft.issn=1521-4036%20(Electronic)%200323-3847%20(Linking)&rft.au=RUSTAND,%20Denis&VAN%20NIEKERK,%20Janet&RUE,%20Havard&TOURNIGAND,%20Christophe&RONDEAU,%20Virginie&rft.genre=article


Files in this item

Thumbnail
Thumbnail

This item appears in the following Collection(s)

Show simple item record